The dvm360® oncology page is a comprehensive resource for clinical news and insights on the latest veterinary oncology This page consists of videos, interviews, articles, podcasts, and research on advancements and developments of therapies for oncology, and more.
In an interview with dvm360®, Sue Ettinger, DVM, DACVIM (Oncology)—Dr Sue Cancer Vet—offers insight about what to tell pet owners when their dog has been diagnosed with lymphoma.
Anivive Lifesciences' Chief Commerical Officer Chad Todd, DVM, offers insight on Laverdia-CA1, the first conditionally approved oral treatment for canine lymphoma.
Virbac’s tigilanol tiglate injections (Stelfonta) has been approved by the FDA for treatment of the most common type of skin cancer in dogs.
During a session at an AVMA Virtual Convention, a veterinary cancer specialist discusses key facts about the disease to help clients make the best decision for their pet.
OncoK9 offers new cancer-detection capabilities enabling veterinarians to provide the highest quality of care to their canine patients.
A survey from the Pet CancerCare Alliance provides insight into pet owners' attitudes about cancer and how likely they are to pursue treatment. (Sponsored by VCA)